PROTOCOL SPECIFIC MATERIALS
6691 DATA FORMS
Form Revision Notices
A0- Form Revision Notice 3.20.13
DV, MM, MR, US 
- Form Revision Notice 6.11.12

IP  -  Form Revision Notice 4.19.11

Forms Index:
                                                             General Form Completion Instructions
6691 Index                                                                         General Form Instructions

Registration Visit                                                                               Instructions
A0 -  Registration                                    
I0 -   Initial evaluation and patient information                                      I0 Instructions
TP -  Chemotherapy Plan                                                                    TP Instructions
IP -   Initial Pathology                                         
 
Visit 1 - 2 weeks post biopsy, prior to treatment
DV --  Visit 1 Evaluation  

Visit 25-10 days after tx initiation
DV -- Visit 2 Evaluation

Visit 3Mid therapy (prior to chemo regimen change)  
DV -- Visit 3 Evaluation

Visit 4Within 3 weeks completion of tx, prior to surgery
DV --  Visit 4 Evaluation
TX -   Chemotherapy Treatment

Post Surgery
SP -    Surgical Pathology

End of Study
DS -   End of Study Disposition

Additional Forms
AE -   Adverse Events
PR -   Protocol Variation
TI  -   Treatment Interruptions
TI  -   Treatment Interruptions Supplemental Form
MM -   SOC Mammography Interpretation
MR -    SOC MRI Interpretation
US -    SOC Ultrasound Interpretation
TP  -    Chemotherapy Plan Supplemental Form                                      TP Instructions


ACRIN Adverse Event (AE) Log




 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For additional information regarding Adverse Events,
please visit ACRIN’s Protocol Development and Regulatory Resources page:
www.acrin.org/pdrc.aspx [Site Link]